Dana Hu-Lowe
Corporate Officer/Principal at ADAGENE INC.
Profile
Dana Hu-Lowe's current job is Vice President-Global Product at Adagene, Inc. Dr. Hu-Lowe's former jobs include Executive Director & Head-Global Product at Turning Point Therapeutics, Inc. and Senior Director-Strategic Alliance & Program at Wellspring Biosciences, Inc. Dr. Hu-Lowe obtained a doctorate degree from the University of Mississippi in 1992 and an undergraduate degree from Beijing Normal University in 1984.
Dana Hu-Lowe active positions
| Companies | Position | Start |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01/11/2021 |
Former positions of Dana Hu-Lowe
| Companies | Position | End |
|---|---|---|
| TURG POIN | Director/Board Member | 01/10/2021 |
| Wellspring Biosciences, Inc. | Corporate Officer/Principal | 01/03/2019 |
Training of Dana Hu-Lowe
| University of Mississippi | Doctorate Degree |
| Beijing Normal University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Private companies | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
| Wellspring Biosciences, Inc. |
- Stock Market
- Insiders
- Dana Hu-Lowe
